<DOC>
	<DOCNO>NCT01446120</DOCNO>
	<brief_summary>This study assess pharmacokinetics efficacy Insulin load Orally Dissolved Films ( insulin-ODF ) treatment . The Insulin-ODF attach inner tissue chick ( buccal ) , Releasing insulin circulation , film dissolved.. Primary endpoint : 1 . The Cmax ( Maximum Concentration insulin mg ) . 2 . Tmax ( time Cmax minute ) 3 . AUC ( Area Under Curve ) blood insulin level six hour trial . Secondary endpoint : 1 . The glucose C-peptide level six hour trial . ( mg ) 2 . The safety treatment descriptive manner record adverse event study population . Methods Seven healthy volunteer randomly assign one follow group : A. Insulin-ODF follow treatment group ; Or B. commercial NPH Insulin treatment . The study design crossover , group treat 3-7 day washout . The volunteer subject arrive clinic eight hour fast . Each subject examine physician , evaluate elegibilities trial ( i.e . inclusion exclusion criterion ) . An I.V catheter administrate assess Glucose , Insulin C-peptide level , ten minute five minute inject NPH Insulin Insulin-ODF . Blood Insulin glucose level evaluate baseline , follow time point : 15,30,60,90,120,150,180,210,240,270,300,330,360 minute . C-peptide level evaluate baseline follow time point : 60,120,240 , 360 minute .</brief_summary>
	<brief_title>Insulin Loaded Orally Dissolved Films ( Insulin-ODF )</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>1 . Signed Informed Consent . 2 . 18.5 &lt; BMI &lt; 30 1 . Smokers . 2 . Known mouth cavity , gum gastrointestinal disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>phase one study . The study population healthy volunteer .</keyword>
</DOC>